Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Eagle Pharmaceuticals Inc.

www.eagleus.com

Latest From GW Pharmaceuticals PLC

Keeping Track: Zelboraf Takes Breakthrough Path For Rare Blood Disease; Teva Resubmits Generic EpiPen

The latest drug development news and highlights from our US FDA Performance Tracker.

Performance Tracker Approvals

Zynerba’s Cannabidiol Failure in Focal Seizures Not So Clear-Cut

Zynerba’s gel formulation of cannabidiol has disappointed in top-line data from a Phase II study in epilepsy patients with focal seizures, but some signals of efficacy in a companion study, and expected data from studies in two other indications, might influence future development plans.

Clinical Trials Research & Development

Pipeline Watch: Top-Line Ozanimod, Romosozumab, Cariprazine Phase III Results

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

GW's Epidolex Epilepsy Data Paves Way For Cannabinoids

Safety and efficacy in study published in New England Journal of Medicine bode well for cannabinoid therapy Epidiolex, which is headed to FDA mid-year.

Neurology Clinical Trials
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Cancer
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Eagle Pharmaceuticals Inc.
  • Senior Management
  • Scott L Tarriff, CEO
    Peter Meyers, CFO
    Steven L Krill, PhD, EVP & CSO
    Sherry Korczynski, SVP, Mktg.
    Adrian Hepner, MD, PhD, EVP & CMO
    Peter Grebow, PhD, EVP, R&D
    Michael Moran, VP, Sales
    David Pernock, Pres. & COO
  • Contact Info
  • Eagle Pharmaceuticals Inc.
    Phone: (201) 326-5300
    50 Tice Blvd.
    Ste. 315
    Woodcliff Lake, NJ 07677
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register